Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Moisture/irritant exclusion from epidermal layer" is not a single molecule or receptor but rather describes a **complex physiological function** performed by the outermost layer of the skin—the **stratum corneum**—and its associated structures. The stratum corneum acts as the principal physical and chemical **barrier to water loss and entry of external irritants or pathogens**[1][3][5]. This protective role is achieved through an organized structure composed primarily of flattened dead cells called **corneocytes**, embedded in a lipid matrix rich in ceramides, cholesterol, and fatty acids[1][2][3]. Key proteins such as filaggrin, involucrin, loricrin, desmogleins/desmocollins (components of desmosomes/corneodesmosomes), and enzymes involved in lipid processing are essential for maintaining this barrier[1][2][5]. Disruption or dysfunction in any component—whether due to genetic mutations affecting structural proteins/lipids or environmental insults—can lead to increased transepidermal water loss (**TEWL**) and heightened susceptibility to irritation/infection. While many drugs or topical agents aim to support this function by enhancing lipid synthesis or keratinocyte differentiation[2], there is no single molecular target that corresponds directly with "moisture/irritant exclusion from epidermal layer." Instead, it represents an emergent property arising from multiple molecular pathways working together. Because this entry does not refer to a specific molecule/receptor/enzyme/transporter but rather a physiological process involving many components, it should be flagged as incorrect for structured drug-target databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal barrier function (specifically, stratum corneum-mediated moisture and irritant exclusion).